Trial watch: Dendritic cell-based anticancer therapy

The use of patient-derived dendritic cells (DCs) as a means to elicit therapeutically relevant immune responses in cancer patients has been extensively investigated throughout the past decade. In this context, DCs are generally expanded, exposed to autologous tumor cell lysates or loaded with specif...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncoimmunology
Auteurs principaux: Bloy, Norma, Pol, Jonathan, Aranda, Fernando, Eggermont, Alexander, Cremer, Isabelle, Fridman, Wolf Hervé, Fučíková, Jitka, Galon, Jérôme, Tartour, Eric, Spisek, Radek, Dhodapkar, Madhav V., Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2014
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292311/
https://ncbi.nlm.nih.gov/pubmed/25941593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.963424
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires